Comments: NJ S3336 | 2018-2019 | Regular Session
Bill Title: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Introduced - Dead) 2019-01-17 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S3336 Detail]
Text: Latest bill text (Introduced) [HTML]
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Introduced - Dead) 2019-01-17 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S3336 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps Debate| Title | PolitiCorps | Access | Comments | Views | Last Post |
|---|---|---|---|---|---|
| There are no visible public or private PolitiCorps discussions concerning the 2018 New Jersey S3336 at this time. | |||||
